Chief Clinical Officer · Pennant Group, Inc. · Common Stock
Side
SELL
Value
$54K
Shares
1,394
Price
$38.52
Executed
Aug 6, 2026
Disclosed
Aug 10, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Aug 6 executedAug 10, 2026 disclosed
PNTG · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Steik Jason Paul filed this Form 4 reporting a open-market sale of PNTG on Aug 6, 2026. It became public on Aug 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Clinical Officer
Steik Jason Paulcik:0002078374
Issuer
Pennant Group, Inc.cik:0001766400
Revision history · 0
No field has changed since this record was first ingested.
